HALSTEAD MICHAEL (EVP and General Counsel) received a stock award from INTRA-CELLULAR THERAPIES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/4/2025ACC: 0000950170-25-013763
Officer· EVP and General Counsel
Since Dec 2018
+50.78K
Net shares
Net buyer
$722.8K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
56.47K acquired · 5.69K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11.02K
Price / share
—
Trade value
—
% of position
New position
1/31/2025
0.00→11.02K
Common Stock
Direct
Shares
−5.69K
Price / share
$127.00
Trade value
$722.76K
% of position
51.7%
1/31/2025
11.02K→5.33K
Total
Net shares
+5.33K
Net value
-$722.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2025 | A · Award | +11.02K | — | — | New position | 0.00 | 11.02K |
| Common Stock Direct | 1/31/2025 | F · Tax Withholding | −5.69K | $127.00 | $722.76K | 51.7% | 11.02K | 5.33K |
| Total | +5.33K | -$722.76K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
45.45K shares
Shares
+45.45K
Strike price
Held after
45.45K
Exercisable
—
2/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock45.45K shares | 2/3/2025 | A · Award | +45.45K | — | 45.45K |